Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Senior Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 16 hours ago

An amazing perspective on #microbes: "An analysis of microbial genes in the human gut and oral microbiomes has yiel… https://t.co/K12cOz3WgZ
@LaVoieGroup

- 19 hours ago

RT @IAmBiotech: The biopharmaceutical industry invests more money back into R&D than any other sector in the country, BIO’s @JimGreenwood e…
@LaVoieGroup

- 1 day ago

Excited for @sciotobio and @nationwidekids, recipients of a $2.3M @NIH grant supporting development of an extended-… https://t.co/prRPJ1wFiI
@LaVoieGroup

- 1 day ago

Biopharma executives: #BostonBD is only a few weeks away! Register today for the opportunity to network and share i… https://t.co/3urtlWzKds

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.